UK Peptide Legal Status & Anti-Doping Matrix
Statutory classification table for all 12 compounds indexed on Trustly Pharma. Cross-referenced against the Human Medicines Regulations 2012 (SI 2012/1916), the Misuse of Drugs Act 1971, and WADA Prohibited List codes.
BPC-157 (Body Protection Compound)
Unlicensed in the UK. Cannot be lawfully marketed or supplied for human clinical administration. Permitted strictly for scientific laboratory investigation.
TB-500 (Thymosin Beta-4 Derivative)
Synthetic 17-amino acid fragment of Thymosin Beta-4. Prohibited by WADA under Section S2. Valid exclusively for preclinical cellular motility assays.
Semax (Heptapeptide ACTH 4-10 Analogue)
Synthetic neuro-active heptapeptide. Unlicensed in the UK/EU. Research supply lawful strictly for neurochemical receptor-binding assays.
Selank (Tuftsin Analogue)
Tuftsin analogue with immunomodulatory and neurotrophic properties in preclinical models. Unapproved for clinical therapeutic use in the UK.
CJC-1295 (with DAC)
Long-acting synthetic GHRH analogue. Strictly prohibited in athletic competition under WADA S2. In vitro endocrinology research reagent only.
Ipamorelin
Selective pentapeptide growth hormone secretagogue (GHS). Non-controlled under UK MDA 1971, but strictly unlicensed for medical delivery.
GHK-Cu (Copper Tripeptide-1)
Copper-chelated tripeptide researched extensively in dermatological collagen synthesis. Permitted for in vitro biochemical and cosmetic chemical characterization.
Epithalon (Epithalamin Synthetic Tetrapeptide)
Synthetic pineal tetrapeptide studied in cellular senescence models and telomerase induction assays. Unlicensed for human therapeutic administration.
MOTS-c (Mitochondrial-Derived Peptide)
16-amino acid mitochondrial peptide encoding AMPK activation. Classified as prohibited under WADA S2. Exclusively for metabolic bioenergetics research.
Tirzepatide
Dual GIP/GLP-1 receptor agonist with UK Marketing Authorisation (Mounjaro). In pure powder form, supply is strictly limited to verified analytical chemical laboratories as reference standards.
Semaglutide
GLP-1 receptor agonist authorized in the UK as Prescription Only Medicine (Wegovy, Ozempic). Raw synthesis batches are reserved exclusively for pharmaceutical research and reference testing.
AOD-9604 (C-Terminal Lipolytic Fragment 177-191)
Modified 16-amino acid C-terminus fragment of human growth hormone. Unlicensed in the UK and prohibited under WADA S2. Permitted for in vitro lipolysis experimentation.
The classifications provided in this matrix reflect current statutory interpretations under UK legislation as of the current calendar year. This information is published solely for educational, academic, and scientific reference and does not constitute formal legal advice. Handling synthetic chemicals must strictly comply with local institutional COSHH assessments and laboratory safety standards.